Smoking cessation in cardiovascular patients.
Stefanatou
Athena
A
2nd University Department of Cardiology, University General Hospital Attikon, Athens, Greece. astefana@otenet.gr
D001552:Benzazepines / Q000008:administration & dosage; D063387:Cannabinoid Receptor Antagonists; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D003376:Counseling; D006801:Humans; D009538:Nicotine / Q000008:administration & dosage; D010880:Piperidines / Q000008:administration & dosage; D011720:Pyrazoles / Q000008:administration & dosage; D011810:Quinoxalines / Q000008:administration & dosage; D000077285:Rimonabant; D012307:Risk Factors; D012907:Smoking / Q000453:epidemiology* / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods; D000074606:Smoking Prevention; D000068580:Varenicline
D001552:Benzazepines; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D011810:Quinoxalines; D009538:Nicotine; D000077285:Rimonabant; D000068580:Varenicline